The changing cigarette, 1950-1995 - PubMed
Review
The changing cigarette, 1950-1995
D Hoffmann et al. J Toxicol Environ Health. 1997 Mar.
Abstract
Nicotine is recognized to be the major inducer of tobacco dependence. The smoking of cigarettes as an advantageous delivery system for nicotine, accelerates and aggravates cardiovascular disease, and is causally associated with increased risks for chronic obstructive lung disease, cancer of the lung and of the upper aerodigestive system, and cancer of the pancreas, renal pelvis, and urinary bladder. It is also associated with cancer of the liver, cancer of the uterine cervix, cancer of the nasal cavity, and myeloid leukemia. In 1950, the first large-scale epidemiological studies documented that cigarette smoking induces lung cancer and described a dose-response relationship between number of cigarettes smoked and the risk for developing lung cancer. In the following decades these observations were not only confirmed by several hundreds of prospective and case-control studies but the plausibility of this causal association was also supported by bioassays and by the identification of carcinogens in cigarette smoke. Whole smoke induces lung tumors in mice and tumors in the upper respiratory tract of hamsters. The particulate matter of the smoke elicits benign and malignant tumors on the skin of mice and rabbits, sarcoma in the connective tissue of rats, and carcinoma in the lungs of rats upon intratracheal instillation. More than 50 carcinogens have been identified, including the following classes of compounds: polynuclear aromatic hydrocarbons (PAH), aromatic amines, and N-nitrosamines. Among the latter, the tobacco-specific N-nitrosamines (TSNA) have been shown to be of special significance. Since 1950, the makeup of cigarettes and the composition of cigarette smoke have gradually changed. In the United States, the sales-weighted average "tar" and nicotine yields have declined from a high of 38 mg "tar" and 2.7 mg nicotine in 1954 to 12 mg and 0.95 mg in 1992, respectively. In the United Kingdom, the decline was from about 32 mg "tar" and 2.2 mg nicotine to less than 12 mg "tar" and 1.0 mg nicotine per cigarette. During the same time, other smoke constituents changed correspondingly. These reductions of smoke yields were primarily achieved by the introduction of filter tips, with and without perforation, selection of tobacco types and varieties, utilization of highly porous cigarette paper, and incorporation into the tobacco blend of reconstituted tobacco, opened and cut ribs, and "expanded tobacco." In most countries where tobacco blends with air-cured (burley) tobacco are used, the nitrate content of the cigarette tobacco increased. In the United States nitrate levels in cigarette tobacco rose from 0.3-0.5% to 0.6-1.35%, thereby enhancing the combustion of the tobacco. More complete combustion decreases the carcinogenic PAH, yet the increased generation of nitrogen oxides enhances the formation of the carcinogenic N-nitrosamines, especially the TSNA in the smoke. However, all analytical measures of the smoke components have been established on the basis of standardized machine smoking conditions, such as those introduced by the Federal Trade Commission, that call for 1 puff to be taken once a minute over a 2-s period with a volume of 35 ml. These smoking parameters may have simulated the way in which people used to smoke the high-yield cigarettes; however, they no longer reflect the parameters applicable to contemporary smokers, and especially not those applicable to the smoking of low- and ultra-low-yield filter cigarettes. Recent smoking assays have demonstrated that most smokers of cigarettes with low nicotine yield take between 2 and 4 puffs per minute with volumes up to 55 ml to satisfy their demands for nicotine. The overview also discusses further needs for reducing the toxicity and carcinogenicity of cigarette smoke. From a public health perspective, nicotine in the smoke needs to be lowered to a level at which there is no induction of dependence on tobacco.
Similar articles
-
Hoffmann D, Djordjevic MV, Hoffmann I. Hoffmann D, et al. Prev Med. 1997 Jul-Aug;26(4):427-34. doi: 10.1006/pmed.1997.0183. Prev Med. 1997. PMID: 9245661 Review.
-
The changing epidemiology of smoking and lung cancer histology.
Wynder EL, Muscat JE. Wynder EL, et al. Environ Health Perspect. 1995 Nov;103 Suppl 8(Suppl 8):143-8. doi: 10.1289/ehp.95103s8143. Environ Health Perspect. 1995. PMID: 8741774 Free PMC article. Review.
-
Formation and analysis of tobacco-specific N-nitrosamines.
Brunnemann KD, Prokopczyk B, Djordjevic MV, Hoffmann D. Brunnemann KD, et al. Crit Rev Toxicol. 1996;26(2):121-37. doi: 10.3109/10408449609017926. Crit Rev Toxicol. 1996. PMID: 8688156 Review.
-
Tobacco-specific nitrosamines in commercial cigarettes: possibilities for reducing exposure.
Fischer S, Spiegelhalder B, Preussmann R. Fischer S, et al. IARC Sci Publ. 1991;(105):489-92. IARC Sci Publ. 1991. PMID: 1855903
-
Assessment of major carcinogenic tobacco-specific N-nitrosamines in Thai cigarettes.
Brunnemann KD, Mitacek EJ, Liu Y, Limsila T, Suttajit M. Brunnemann KD, et al. Cancer Detect Prev. 1996;20(2):114-21. Cancer Detect Prev. 1996. PMID: 8706036
Cited by
-
Berg CJ, Carpenter MJ, Jardin B, Ostroff JS. Berg CJ, et al. J Cancer Surviv. 2013 Mar;7(1):44-54. doi: 10.1007/s11764-012-0243-9. Epub 2013 Jan 10. J Cancer Surviv. 2013. PMID: 23307036 Free PMC article.
-
The dirty dozen: 12 myths that undermine tobacco control.
Frieden TR, Blakeman DE. Frieden TR, et al. Am J Public Health. 2005 Sep;95(9):1500-5. doi: 10.2105/AJPH.2005.063073. Epub 2005 Jul 28. Am J Public Health. 2005. PMID: 16051930 Free PMC article. Review.
-
Chaudhry IS, El-Meanawy A, Khiyami A, Tomashefski JF Jr, Machekano RN, Kass L. Chaudhry IS, et al. J Oncol. 2011;2011:208563. doi: 10.1155/2011/208563. Epub 2011 Apr 5. J Oncol. 2011. PMID: 21776270 Free PMC article.
-
Influence of Smoking in the Clinical Outcomes of Distal Radius Fractures.
Kaneko A, Naito K, Obata H, Nagura N, Sugiyama Y, Goto K, Kawakita S, Iwase Y, Kaneko K. Kaneko A, et al. J Hand Microsurg. 2020 Aug 5;14(3):212-215. doi: 10.1055/s-0040-1715425. eCollection 2022 Jul. J Hand Microsurg. 2020. PMID: 36016643 Free PMC article.
-
Landy R, Cheung LC, Young CD, Chaturvedi AK, Katki HA. Landy R, et al. Cancer. 2024 Jan;130(2):201-215. doi: 10.1002/cncr.34758. Epub 2023 Nov 1. Cancer. 2024. PMID: 37909885 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous